<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bell RM</submitter><funding>Singapore Ministry of Health’s National Medical Research Council</funding><funding>British Heart Foundation</funding><funding>Rosetrees Trust</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>National Institute for Health Research (NIHR)</funding><funding>National Research Foundation Singapore</funding><funding>PGC</funding><funding>Duke-NUS Signature Research Programme</funding><pagination>39</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9377667</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>117(1)</volume><pubmed_abstract>The Hatter Cardiovascular Institute biennial workshop, originally scheduled for April 2020 but postponed for 2 years due to the Covid pandemic, was organised to debate and discuss the future of Remote Ischaemic Conditioning (RIC). This evolved from the large multicentre CONDI-2-ERIC-PPCI outcome study which demonstrated no additional benefit when using RIC in the setting of ST-elevation myocardial infarction (STEMI). The workshop discussed how conditioning has led to a significant and fundamental understanding of the mechanisms preventing cell death following ischaemia and reperfusion, and the key target cyto-protective pathways recruited by protective interventions, such as RIC. However, the obvious need to translate this protection to the clinical setting has not materialised largely due</pubmed_abstract><journal>Basic research in cardiology</journal><pubmed_title>Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop.</pubmed_title><pmcid>PMC9377667</pmcid><funding_grant_id>FS/18/80/33937</funding_grant_id><funding_grant_id>M565</funding_grant_id><funding_grant_id>NMRC CG21APR1006</funding_grant_id><funding_grant_id>-</funding_grant_id><funding_grant_id>MOH-STaR21jun-0003</funding_grant_id><funding_grant_id>CRC 1116 B8</funding_grant_id><funding_grant_id>FS/CRTF/21/24251</funding_grant_id><funding_grant_id>PG/21/10798</funding_grant_id><funding_grant_id>2018-094025-B-I00</funding_grant_id><funding_grant_id>MCIN/AEI/10.13039/501100011033</funding_grant_id><funding_grant_id>NIHR128240</funding_grant_id><funding_grant_id>PG/19/51/34493</funding_grant_id><funding_grant_id>PG/18/10/33550</funding_grant_id><funding_grant_id>NMRC/CG21APRC006</funding_grant_id><pubmed_authors>Bell RM</pubmed_authors><pubmed_authors>Hausenloy DJ</pubmed_authors><pubmed_authors>Ibanez B</pubmed_authors><pubmed_authors>Ntsekhe M</pubmed_authors><pubmed_authors>England TJ</pubmed_authors><pubmed_authors>Yellon DM</pubmed_authors><pubmed_authors>Cunningham J</pubmed_authors><pubmed_authors>Walker JM</pubmed_authors><pubmed_authors>Lecour S</pubmed_authors><pubmed_authors>Beikoghli Kalkhoran S</pubmed_authors><pubmed_authors>Davidson SM</pubmed_authors><pubmed_authors>Basalay M</pubmed_authors><pubmed_authors>Ghosh AK</pubmed_authors><pubmed_authors>Kleinbongard P</pubmed_authors><pubmed_authors>Giesz S</pubmed_authors><pubmed_authors>Lukhna K</pubmed_authors><pubmed_authors>Ovize M</pubmed_authors><pubmed_authors>Heusch G</pubmed_authors><pubmed_authors>Vilahur G</pubmed_authors><pubmed_authors>Carr RD</pubmed_authors><pubmed_authors>Golforoush P</pubmed_authors><pubmed_authors>Botker HE</pubmed_authors><pubmed_authors>Gourine AV</pubmed_authors><pubmed_authors>Salama AD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop.</name><description>The Hatter Cardiovascular Institute biennial workshop, originally scheduled for April 2020 but postponed for 2 years due to the Covid pandemic, was organised to debate and discuss the future of Remote Ischaemic Conditioning (RIC). This evolved from the large multicentre CONDI-2-ERIC-PPCI outcome study which demonstrated no additional benefit when using RIC in the setting of ST-elevation myocardial infarction (STEMI). The workshop discussed how conditioning has led to a significant and fundamental understanding of the mechanisms preventing cell death following ischaemia and reperfusion, and the key target cyto-protective pathways recruited by protective interventions, such as RIC. However, the obvious need to translate this protection to the clinical setting has not materialised largely due</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-05-29T14:36:46.506Z</modification><creation>2024-12-03T16:23:05.382Z</creation></dates><accession>S-EPMC9377667</accession><cross_references><pubmed>35970954</pubmed><doi>10.1007/s00395-022-00947-2</doi></cross_references></HashMap>